CRISPR Therapeutics AG (CRSP)
53.99
-0.65
(-1.19%)
USD |
NASDAQ |
Feb 20, 10:49
CRISPR Therapeutics Profit Margin (Quarterly) : -15.12K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Beam Therapeutics, Inc. | -1.16K% |
| Novartis AG | 18.03% |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.23% |
| Return on Assets | -26.56% |
| Return on Invested Capital | -28.00% |
| Gross Profit Margin (Quarterly) | -6.77K% |
| Operating Margin (Quarterly) | -17.91K% |
| Return on Net Operating Assets | -217.4% |